Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 18 Neoplasms 12 Kidney Neoplasms 6 Breast Neoplasms 6 Stomach Neoplasms 4 Neoplasm Metastasis 4 Gastrointestinal Stromal Tumors 4 Carcinoma, Non-Small-Cell Lung 4 Solid Tumors 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Glioma 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Brain Neoplasms 2 Advanced Cancer 2

Interventions

Cyclophosphamide 14 Gemcitabine 6 Filgrastim 6 fludarabine 5 Methotrexate 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Zoledronic Acid 4 Temozolomide 4 Mesna 4 Irinotecan 4 Ifosfamide 4 Etoposide 4 Cisplatin 4 Carboplatin 4 pembrolizumab 3 fludarabine phosphate 3 Doxorubicin 3 Biopsy 3 tanespimycin 2 poly ICLC 2 pegfilgrastim 2 lorukafusp alfa 2 liposomal doxorubicin 2 dinutuximab 2 cabozantinib 2 belinostat 2 Topotecan 2 Thalidomide 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Osteosarcoma × Sunitinib × Clear all

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

University of Colorado, Denver

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡